Garware Fulflex acquires medical products manufacturing facility in Texas

Garware Fulflex has announced the completion of its acquisition of a 300,000-square-foot medical products manufacturing facility in Jacksonville, Texas, expanding its manufacturing footprint in North America.

According to the company, the facility is situated on a 30-acre campus, employs more than 250 people and manufactures a range of medical products used by healthcare providers and patients across North America and other markets.

The company stated that the facility includes injection moulding, blow moulding, thermoforming, extrusion, assembly and quality systems, supporting its manufacturing capabilities for healthcare companies.

According to Garware Fulflex, the acquisition expands its manufacturing presence in the United States and forms part of its long-term strategy to build a global healthcare manufacturing platform.

Commenting on the acquisition, Diya Garware Ibanez, Chairperson, Garware Fulflex, said, “This acquisition represents a defining milestone in our journey to build a globally respected healthcare manufacturing company. The Jacksonville facility brings exceptional people, world-class manufacturing capabilities, and an important presence in the world’s largest healthcare market. Most importantly, we are proud to welcome more than 250 talented employees to the Fulflex family. Together, we will continue delivering high-quality medical products while investing in innovation, operational excellence, and long-term growth.”

With the addition of the Jacksonville facility, the company stated that it has expanded its global manufacturing network to provide customers with increased production capacity, technical expertise, supply chain resilience and closer access to the North American healthcare market.